Shukun Technology, a forefront player in China's medical AI landscape, welcomed a foreign media delegation organized by the China International Press Communication Center. The visit aimed to delve into the potential of artificial intelligence in advancing the "Belt and Road" initiative and explore the transformative impact of AI-healthcare integration on a global scale.

At the heart of Shukun's headquarters, international journalists gained firsthand insights into the company's strides in advancing the digitization and intelligence of healthcare. Since its establishment in 2017, Shukun Technology has independently developed over 40 AI products spanning screening, diagnosis, treatment, and monitoring of major illnesses, showcasing the power of its groundbreaking "Digital Body" technology platform.

The company's commitment to revolutionizing healthcare was evident as journalists witnessed how Shukun's AI solutions not only aid medical professionals in accurate disease identification and precise surgical planning but also elevate hospital management efficiency. This translates to more accessible, timely, and high-quality healthcare services for patients.

Anne Ma, the visionary CEO of Shukun Technology, engaged with journalists, highlighting the global scarcity of medical resources and the company's steadfast commitment to building a global community of shared future. Emphasizing Shukun's dedication to enhancing global health through cutting-edge AI-powered healthcare solutions, Anne Ma envisioned strengthened collaboration with countries participating in the "Belt and Road" initiative.

Wang Rui, Shukun Technology's Co-Chief Financial Officer, outlined the company's international expansion strategy. Actively involved in international cooperation, Shukun has established collaborative partnerships with medical institutions and research academies worldwide. The company has garnered 4 EU MDR CE certifications and 2 US FDA certifications, underscoring its commitment to openness, collaboration, and mutual benefit.

Journalists were not only immersed in the cutting-edge advancements of the healthcare AI industry but also treated to vivid case studies and discussions on maximizing AI's potential to promote human health. The visit solidified the belief in the significant value of the "Belt and Road" initiative in driving global health and well-being.

In its tenth year, the initiative has not only facilitated economic cooperation but has also paved new avenues for global health improvement. Shukun Technology is poised to contribute to this mission by strengthening international exchanges and collaborations, leveraging innovation in medical AI technology.

At the convergence of "artificial intelligence + healthcare," Shukun Technology stands as a global leader, pioneering the fusion of AI with medical imaging. Over the past six years, the company has consistently pushed the boundaries of industry technology, offering comprehensive, intelligent, and innovative smart health solutions.

Shukun's groundbreaking AI products for coronary arteries, head and neck, and liver have received global recognition, with FDA and MDR CE certifications underscoring their international acclaim. The company's partnerships with over 300 leading hospitals worldwide and research collaborations with renowned institutions reflect its commitment to advancing medical research on a global scale.

Currently, Shukun's products and solutions are in high demand, actively utilized by over 3,000 healthcare institutions in China, including 90% of the country's top 100 hospitals. Shukun Technology's cutting-edge solutions, touching the lives of over 100 million people annually, contribute significantly to the global cause of human health.